rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Guru Terug naar discussie overzicht

***** GTCB 2007 ******

2.783 Posts
Pagina: «« 1 ... 56 57 58 59 60 ... 140 »» | Laatste | Omlaag ↓
  2. [verwijderd] 5 april 2007 20:58

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    begrijp sosieso de amerikaanse manier van handelen niet. zet er 2k in op 1.20; krijg er direct 900 en 300, daarna gaan er weer zo'n 15k en dan ineens komen de laatste 800. Schiet mij maar lek;)
    .eurokloner.
  4. [verwijderd] 5 april 2007 21:03

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    zei ik gistren al dree :))0

    pretvogel () @4/3/2007 10:04:56 PM Blokkeer
    1,14 toch 5 cent in de plus
    mama crash





    pretvogel () @4/3/2007 9:59:34 PM Blokkeer
    fundamenteel moeten ze toch een ker geld gaan ophalen :))
    mama crash





    pretvogel () @4/3/2007 9:59:11 PM Blokkeer
    ja kan morgen weer verder up is de laatste weken aandacht genoeg
    mama crash

    geluksvogel
  16. [verwijderd] 9 april 2007 15:15

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    GTC Biotherapeutics (NasdaqGM: GTCB): CEO, President and Chairman Geoffrey Cox continues to make small purchases of this microcap biotech company, which recently expanded the license for its anti-nerve agent therapy.
    geluksvogel
  18. $rob$ 9 april 2007 19:40

    • $rob$

      Lid sinds: 01 jan 2000

      Laatste bezoek: 27 feb 2025

    • Aanbevelingen

      Ontvangen: 258

      Gegeven: 65

    •    Aantal posts: 1.967

    Blijven een beetje hangen rond de 1,20. Zuur, als je ziet wat er bij DNDN gebeurt. Ongelofelijk. Leuk voor de mensen die Dendreon in hun porto hebben. Ik heb niet de illusie dat dit soort koersstijgingen bij GTCB of Pharming gaan gebeuren.
    rob
  20. [verwijderd] 10 april 2007 15:17

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    GTC BIOTHERAPEUTICS OBTAINS LICENSE TO NUCLEAR TRANSFER PATENTS


    FRAMINGHAM, MA – April 10, 2007 -- GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today that it has been granted a non-exclusive worldwide license from Start Licensing, Inc., a joint venture between Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc., for the patents and patent applications developed by the Roslin Institute to apply nuclear transfer to the production of therapeutic proteins in the milk of transgenic animals. Nuclear transfer may be utilized, as an alternative to micro-injection, to provide schedule predictability in developing the first animal that incorporates into its genome the transgene for a therapeutic protein to be expressed in milk. Nuclear transfer may also be used to speed the development of large scale transgenic production capacity. Financial terms include an upfront payment of $200,000 to Start and a total of 278,370 shares of GTCB common stock, based on the 10-day average closing price ending April 5, divided equally between Start and Exeter. There will also be a royalty payable to Start for those products developed with the patented nuclear transfer technology. The license agreement remains in place through the last patent to expire, which is expected in 2016 for the currently issued patents.



    “We are pleased to enter into this licensing agreement to ensure we have the freedom to operate for those programs where the application of nuclear transfer is appropriate for product development,” stated Geoffrey F. Cox, Ph.D., GTC’s Chairman of the Board and Chief Executive Officer. “Our intellectual property portfolio provides patent protection for both the practice of our technology and the commercialization of our products. Last year, we received a patent in the United States for the production of therapeutic proteins in the milk of any transgenic mammal through 2021. This broad and long-lived intellectual property, all of which is independent of traditional bioreactor-based intellectual property, supports our strategic focus on the development and commercialization of recombinant plasma proteins and monoclonal antibodies.”



    About Start Licensing

    Start is a joint venture of the Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a broad portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology that was developed at the Roslin Institute for the cloning of Dolly the sheep. Start’s licensees are on the cutting edge of research and product development in food production, medical applications and many other fields

    tis vandaag
2.783 Posts
Pagina: «« 1 ... 56 57 58 59 60 ... 140 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.032
AB InBev 2 5.512
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.711
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.721
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.866
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.894
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.890
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.278
AMG 971 133.551
AMS 3 73
Amsterdam Commodities 305 6.691
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.011
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.781
Arcelor Mittal 2.033 320.728
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.318
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.204
ASML 1.766 107.624
ASR Nederland 21 4.499
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.678
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392